To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.

 
 

Description

Dry eye disease (DED) is a multifactorial ocular condition, where disrupted tear film stability and ocular surface inflammation affected between 5% to 34% of the worldwide population in 2015 and posed a challenge to conventional ophthalmic treatments. Recent advances have led to potential novel therapeutics aiming to alleviate symptoms and improve patient outcomes.

Disciplines

Eye Diseases | Laboratory and Basic Science Research | Medical Education | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Other Medical Sciences | Pharmaceutical Preparations | Pharmaceutics and Drug Design | Pharmacology

Document Type

Event

Share

COinS
 

Evaluation of Novel Therapeutic Agents for the Treatment of Chronic Dry Eyes

Dry eye disease (DED) is a multifactorial ocular condition, where disrupted tear film stability and ocular surface inflammation affected between 5% to 34% of the worldwide population in 2015 and posed a challenge to conventional ophthalmic treatments. Recent advances have led to potential novel therapeutics aiming to alleviate symptoms and improve patient outcomes.